Schizophrenia, cardiometabolic and other medical comorbidity

Our work aims to determine the magnitude and range of cardiometabolic health problems in people with schizophrenia and related enduring psychotic illnesses. It will also identify – at the earliest possible stage – those high-risk patients for whom intensive interventions are more likely to be of value in forestalling premature morbidity and mortality.

Schizophrenia is an incurable, relapsing and extraordinarily disabling mental health disorder. It has been described as “arguably the worst disease affecting mankind” in the scientific journal Nature. The enormous burden of associated physical comorbidities that contribute to markedly premature mortality goes largely unrecognised.